Emerging pathogens in cystic fibrosis

P. Drevinek (Praha, Czech Republic)

Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Session: State of the art session: Paediatric respiratory diseases
Session type: Symposium
Number: 3746
Disease area: Paediatric lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Drevinek (Praha, Czech Republic). Emerging pathogens in cystic fibrosis. International Congress 2019 – State of the art session: Paediatric respiratory diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Emerging pathogens in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66
Year: 2006

Temporal progression of fungal microbiota in patients with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


The spectrum of Nocardia lung disease in cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Cystic fibrosis microbiology, emerging pathogens and more treatment options
Source: International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children
Year: 2018


Current concepts: host–pathogen interactions in cystic fibrosis airways disease
Source: Eur Respir Rev 2014; 23: 320-332
Year: 2014



Emerging role of difficult microrganisms in respiratory tract infections of patients with cystic fibrosis with or without lung transplantation
Source: Eur Respir J 2003; 22: Suppl. 45, 514s
Year: 2003

Anaerobic bacteria and host defence in cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013


Non-tuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019


Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010

Managing antimicrobial resistance in cystic fibrosis
Source: International Congress 2014 – ERS/Lancet and Lancet Respiratory Medicine joint session: complicating infections in respiratory disease and critical care
Year: 2014



Respiratory infections in cystic fibrosis
Source: ERS Courses: Paediatric respiratory infections
Year: 2019


Cystic fibrosis
Source: Respipedia Article
Year: 2018

Fungi communities detected by metagenomic tools in sputum in patients with cystic fibrosis
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Microevolution of pseudomonas aeruginosa in cystic fibrosis lungs
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Host specificity of pseudomonas aeruginosa isolates from patients with cystic fibrosis and patients from different clinical backgrounds
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014


Practical microbiology of cystic fibrosis lung disease
Source: School Course 2013 - Cystic Fibrosis
Year: 2013

Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
Source: Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019
Year: 2019



Novel therapeutics for cystic fibrosis
Source: ERS Webinar 2020: Novel therapeutics for cystic fibrosis
Year: 2020